tiprankstipranks
Abeona Therapeutics (ABEO)
NASDAQ:ABEO
US Market
ABEO
Abeona Therapeutics
RESEARCH TOOLSreports

Abeona Therapeutics (ABEO) Financial Statements

Compare
1,538 Followers

Abeona Therapeutics Financial Overview

Abeona Therapeutics's market cap is currently $247.02M. The company's EPS TTM is $-0.36; its P/E ratio is 3.92; Abeona Therapeutics is scheduled to report earnings on March 17, 2026, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Mar 22
Income Statement
Total Revenue$ 5.82M$ 0.00$ 3.50M$ 1.41M$ 3.00M
Gross Profit$ 4.29M$ -2.91M$ 1.90M$ 964.00K$ 3.00M
Operating Income$ -89.45M$ -64.21M$ -47.13M$ -50.91M$ -89.84M
EBITDA$ -85.89M$ -56.62M$ -50.57M$ -34.38M$ -76.82M
Net Income$ 71.18M$ -63.73M$ -54.19M$ -39.70M$ -84.94M
Balance Sheet
Cash & Short-Term Investments$ 191.40M$ 97.72M$ 52.23M$ 52.15M$ 45.02M
Total Assets$ 219.57M$ 108.93M$ 64.00M$ 64.21M$ 79.59M
Total Debt$ 24.97M$ 23.05M$ 5.40M$ 7.63M$ 9.38M
Net Debt$ -53.47M$ -309.00K$ -9.07M$ -6.59M$ -23.56M
Total Liabilities$ 60.35M$ 64.90M$ 49.18M$ 37.45M$ 37.22M
Stockholders' Equity$ 159.22M$ 44.03M$ 14.83M$ 26.76M$ 42.37M
Cash Flow
Free Cash Flow$ -84.30M$ -58.46M$ -37.34M$ -43.61M$ -69.82M
Operating Cash Flow$ -76.33M$ -56.02M$ -37.01M$ -43.48M$ -65.67M
Investing Cash Flow$ 105.03M$ -39.24M$ 208.00K$ -23.96M$ 66.06M
Financing Cash Flow$ 26.04M$ 104.14M$ 37.06M$ 43.17M$ 24.86M
Currency in USD

Abeona Therapeutics Earnings and Revenue History

Income Statement >

Abeona Therapeutics Debt to Assets

Balance Sheet >

Abeona Therapeutics Cash Flow

Cash Flow >

Abeona Therapeutics Forecast EPS vs Actual EPS

Earnings >